Boston was pretty dead, but here are some observations and research summaries I put together to liven things up on the way back.
Read More
The current cohort analysis, which suggests that hospitalizations are stable as a percent of cases and deaths are declining.
Read More
A couple of observations to start the week, but a slow research day.
Read More
I am sure on a lovely Sunday morning you have nothing better to do than read research summaries, so here they are.
Read More
Watching the age group percents for cases, hospitalizations and deaths tells us a lot.
Read More
The IB is caught red-handed trying to make up after the fact justifications for his actions.
Read More
A revealing response from the CDC to a request for data on mask policies.
Read More
A light day for research and we were blessed with a second coronavirus briefing this week.
Read More
More messaging from the state DOH and some immune response heavy research.
Read More
I have been writing this blog for a long time and I thought I had seen some wild times for investments and valuations, but this is insane. Every day, multiple new investments at very high valuation. CareSyntax, which offers software to help collect data on surgeries and help with decision support, raised $100 million in new capital. If I can't understand how a company can possibly deliver that much value, something is seriously wrong.
https://www.fiercehealthcare.com/tech/caresyntax-hauls-100m-to-expand-its-surgical-data-analysis-business?mkt_tok=Mjk0LU1RRi0wNTYAAAF8uMKNd9gxQnguNTRSEfrOPAt47mKTRWmftgDg69_7Ca0E9R1oqbi6C0x9-iNRbq3EjYe-KF3Vc5DUPOQItgiypvN9pJJdL-_aR7i-lvpE9L9YYIs&mrkid=635530Capsule, which operates a "digital" pharmacy raised $300 million in additional capital. You can't have a health care business if it isn't digital, no matter how pedestrian its business. Craziness in the capital markets.
https://www.fiercehealthcare.com/tech/digital-pharmacy-startup-capsule-clinches-300m-to-invest-one-stop-shop-for-digital-healthcare?mkt_tok=Mjk0LU1RRi0wNTYAAAF8uMKNdzQWDEBmrXCSal1TsfHgOMlwjHZWHLimXR4M7FF9g1laXUb2VHdCpPQT8Q0l-Zf63tUUNsFyiTTE4ubx3pj4RYXOdvZcqafKiWlzL3rx_cY&mrkid=635530Digital health is a wasteland. Someone has developed an app or multiple apps for every possible disease or condition. These are all commodities and generally provide little real value, but investors are pouring money into them at very high valuations. Sorry to piss all over the idea, but here is an example, a company called Renovia raised $17 million for an app to help manage urinary continence. More specifically, the app will help with exercises for pelvic floor disorders. Well, I am floored by the investment and valuation.
https://medcitynews.com/2021/04/startup-making-digital-therapeutic-for-pelvic-floor-disorders-raises-17m/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_medium=email&_hsmi=123952328&_hsenc=p2ANqtz--JPMQoRHMukC-Rc3EAq_WSZQSe9f5fYiRBUwrRHpv1oCunliqqDvm_uqzQJ9zJU1HXonPNkpuhFMPrm6NWsRDMBole_6OM_WNkw7JlfxlXv0Dtrwg&utm_content=123952328&utm_source=hs_email&rf=1Privia Health, which provides administrative and patient engagement software to physician practices, is planning to go public by raising over $300 million, which would value the company at almost $2 billion. Valuations are absurd.
https://medcitynews.com/2021/04/privia-health-launches-ipo-aims-to-raise-up-to-370m/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_medium=email&_hsmi=123952328&_hsenc=p2ANqtz--MOXqv6wcLR1zlqFF9hXfc7yZpNUjiVO2Eqaf_7oAaiR1cVotSeO5674wGQIQ1C1uvcjgpgZiTFMHhcJI3-W3KTYwtPghJHg9hk6dtJ47axFnAHf4&utm_content=123952328&utm_source=hs_email&rf=1About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts